GANX
Price
$1.67
Change
-$0.12 (-6.70%)
Updated
Apr 4, 02:38 PM (EDT)
Capitalization
50.02M
33 days until earnings call
MDGL
Price
$318.73
Change
-$8.37 (-2.56%)
Updated
Apr 4, 02:44 PM (EDT)
Capitalization
7.23B
39 days until earnings call
Ad is loading...

GANX vs MDGL

Header iconGANX vs MDGL Comparison
Open Charts GANX vs MDGLBanner chart's image
Gain Therapeutics
Price$1.67
Change-$0.12 (-6.70%)
Volume$999
Capitalization50.02M
Madrigal Pharmaceuticals
Price$318.73
Change-$8.37 (-2.56%)
Volume$200
Capitalization7.23B
GANX vs MDGL Comparison Chart
Loading...
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GANX vs. MDGL commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GANX is a Hold and MDGL is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (GANX: $1.79 vs. MDGL: $327.10)
Brand notoriety: GANX and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GANX: 84% vs. MDGL: 61%
Market capitalization -- GANX: $50.02M vs. MDGL: $7.23B
GANX [@Biotechnology] is valued at $50.02M. MDGL’s [@Biotechnology] market capitalization is $7.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GANX’s FA Score shows that 0 FA rating(s) are green whileMDGL’s FA Score has 1 green FA rating(s).

  • GANX’s FA Score: 0 green, 5 red.
  • MDGL’s FA Score: 1 green, 4 red.
According to our system of comparison, MDGL is a better buy in the long-term than GANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GANX’s TA Score shows that 2 TA indicator(s) are bullish while MDGL’s TA Score has 2 bullish TA indicator(s).

  • GANX’s TA Score: 2 bullish, 6 bearish.
  • MDGL’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, MDGL is a better buy in the short-term than GANX.

Price Growth

GANX (@Biotechnology) experienced а -13.53% price change this week, while MDGL (@Biotechnology) price change was -3.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.78%. For the same industry, the average monthly price growth was -16.56%, and the average quarterly price growth was -18.36%.

Reported Earning Dates

GANX is expected to report earnings on May 07, 2025.

MDGL is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-10.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($7.23B) has a higher market cap than GANX($50M). MDGL YTD gains are higher at: 6.005 vs. GANX (-17.130). GANX has higher annual earnings (EBITDA): -21.34M vs. MDGL (-450.12M). MDGL has more cash in the bank: 926M vs. GANX (12M). GANX has less debt than MDGL: GANX (769K) vs MDGL (120M). MDGL has higher revenues than GANX: MDGL (180M) vs GANX (0).
GANXMDGLGANX / MDGL
Capitalization50M7.23B1%
EBITDA-21.34M-450.12M5%
Gain YTD-17.1306.005-285%
P/E RatioN/AN/A-
Revenue0180M-
Total Cash12M926M1%
Total Debt769K120M1%
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
27
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
26

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GANXMDGL
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 23 days ago
79%
Bullish Trend 12 days ago
78%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 10 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
62%
View a ticker or compare two or three
Ad is loading...
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RWX24.770.26
+1.06%
SPDR® Dow Jones® International RelEstETF
TDTF24.200.22
+0.92%
FlexShares iBoxx 5Yr Target Dur TIPS ETF
FTSM59.900.05
+0.08%
First Trust Enhanced Short Maturity ETF
MIG21.34-0.01
-0.04%
VanEck IG Corporate ETF
PSMD28.08-0.80
-2.77%
Pacer Swan SOS Moderate (January) ETF

GANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GANX has been loosely correlated with AXON. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if GANX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GANX
1D Price
Change %
GANX100%
-5.29%
AXON - GANX
36%
Loosely correlated
-3.35%
MDGL - GANX
34%
Loosely correlated
-2.24%
ARRY - GANX
34%
Loosely correlated
-10.32%
VXRT - GANX
31%
Poorly correlated
+8.34%
ALLK - GANX
31%
Poorly correlated
-0.40%
More

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with KANT. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then KANT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
-2.24%
KANT - MDGL
62%
Loosely correlated
-3.88%
ALXO - MDGL
56%
Loosely correlated
-10.48%
ZNTL - MDGL
51%
Loosely correlated
-7.55%
CGEM - MDGL
50%
Loosely correlated
-4.22%
TSVT - MDGL
50%
Loosely correlated
+0.20%
More